NCT05182060 is a NA clinical trial of Transition Intervention in Transitional Care, sponsored by Johns Hopkins University.

Who is sponsoring NCT05182060?

NCT05182060 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT05182060?

Interventions in NCT05182060: Transition Intervention.

What condition does NCT05182060 study?

NCT05182060 studies Transitional Care, Frail Elderly, Home Health Care.

Is NCT05182060 still recruiting?

NCT05182060 is currently completed. Last updated 23 August 2023.

Last reviewed 2023-08-23 · How we verify

NCT05182060

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Making Health Care Safer for Older Adults Receiving Skilled Home Health Care Services After Hospital Discharge

Completed NA Last updated 23 August 2023

What this trial tests

NA trial testing Transition Intervention in Transitional Care in 761 participants. Completed in 31 July 2023.

Timeline

7 April 2022

Primary endpoint
20 June 2023

31 July 2023

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	761
Start date	7 April 2022
Primary completion	20 June 2023
Estimated completion	31 July 2023
Sites	1 location across United States

Drugs / interventions tested

Transition Intervention

Conditions studied

Transitional Care — all drugs for Transitional Care →
Frail Elderly — all drugs for Frail Elderly →
Home Health Care — all drugs for Home Health Care →

Sponsor

Johns Hopkins University

Who can join

65 and older, any sex, with Transitional Care or Frail Elderly. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Care transitions are the movement of a person from one healthcare setting to another. Older adults who require skilled home health care ("home health") services (e.g., home-based nursing) after hospital discharge are at high risk of experiencing early re-hospitalization. Home health agencies need strategies to ensure safe transitions, yet there is relatively little research to guide improvement efforts. The goal of the study is to develop and test tools to allow home health agencies to identify and act upon threats to older adults' safety in real time. The investigators first analyzed threats to older adult safety during hospital-to-home health transitions and refined a bundle of interventions through stakeholder engagement. This prospective pilot will implement and measure the bundle of interventions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Coming Home Intervention to Enhance Safe Hospital-to-Home Health Transitions: Pilot Evaluation.
Arbaje AI, Hsu YJ, Greyson S, Bowles KH, et al · · 2026 · cited 1× · PMID 40099951 · DOI 10.1097/qmh.0000000000000519

Verify or expand the search:

Other trials of Transition Intervention

Trials testing the same drug.

NCT04888273 — Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services · NA · completed

Other recruiting trials for Transitional Care

Currently open trials in the same condition.

NCT07310199 — Pharmacist-Led Transition of Care Program in the Emergency Department (Pharm TOC-ED): A Pilot Trial · NA · recruiting
NCT06242366 — Transitional Care Program in Stroke Patients With Hemiplegia. · NA · recruiting
NCT06190288 — AdvantAGE: Implementation and Evaluation of an Interprofessional Tranistional Care Model for Frail Older Adults · NA · recruiting
NCT05806606 — Effect and Cost Effectiveness of a Dyadic Empowerment-based Heart Failure Management Program for Self-care · NA · active not recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05182060 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 23 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05182060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing